deamino-arginine-vasopressin and Blindness

deamino-arginine-vasopressin has been researched along with Blindness* in 3 studies

Other Studies

3 other study(ies) available for deamino-arginine-vasopressin and Blindness

ArticleYear
Hypothalamic-pituitary Langerhans cell histiocytosis: a diagnostic challenge.
    Annales d'endocrinologie, 2000, Volume: 61, Issue:6

    Four cases of hypothalamic-pituitary Langerhans cell histiocytosis (LCH) are reported, highlighting the expanding spectrum of clinical and magnetic resonance imaging (MRI) features in adults. The diagnostic challenge of hypothalamic-pituitary LCH is emphasized in cases revealed as supra-sellar tumors with panhypopituitarism or as isolated central diabetes insipidus. Diagnosis is confirmed by histological examination showing infiltration with CD1a positive histiocytes. General guidelines for diagnosis procedure are drawn out, including the neurosurgical biopsy in particular cases.

    Topics: Adult; Aged; Blindness; Deamino Arginine Vasopressin; Fatal Outcome; Female; Histiocytosis, Langerhans-Cell; Humans; Lung Diseases; Magnetic Resonance Imaging; Male; Pituitary Diseases; Pituitary Neoplasms; Renal Agents

2000
The role of arginine-vasopressin for pineal melatonin synthesis in the rat: involvement of vasopressinergic receptors.
    Neuroscience letters, 1991, Feb-11, Volume: 123, Issue:1

    The endogenously synthesized nonapeptide arginine vasopressin (AVP) is thought to be involved in transduction of photic information to the pineal gland. The enhancement of circulating AVP leads to a suppression of the nocturnal melatonin surge the mechanisms of which are unknown so far. We therefore studied the effect of dDAVP, an AVP analog with antidiuretic but without vasopressor activity, on pineal melatonin synthesis in Sprague-Dawley and AVP-deficient Brattleboro rats. The nocturnal intra-arterial application of dDAVP mimicked the inhibitory effect of AVP on the activity of the rate-limiting enzyme for pineal melatonin synthesis, N-acetyltransferase (NAT), in both rat strains. Furthermore, since the pineal is equipped with receptors for VP4-9 (the major proteolytic AVP fragment) only, the influence of this substance on the gland's metabolic activity was investigated in vitro. Neither this peptide nor AVP alone did not affect NAT activity, but either substance potentiated the norepinephrine-induced enhancement of NAT activity. These results reveal that at least two mechanisms mediate the influence of AVP on pineal melatonin synthesis. The AVP-induced pineal inhibition in vivo is probably due to a receptor-mediated effect on pinealopetal signal transduction. This inhibition masks the potentiating effect of AVP on the pineal gland itself which is delayed by the conversion of AVP to VP4-9. The present results support the idea of a modulatory role of AVP and its metabolites in the generation and maintenance of the circadian melatonin rhythm in mammals.

    Topics: Animals; Arginine Vasopressin; Arylamine N-Acetyltransferase; Blindness; Deamino Arginine Vasopressin; Injections, Intra-Arterial; Male; Melatonin; Pineal Gland; Rats; Rats, Brattleboro; Rats, Inbred Strains; Receptors, Angiotensin; Receptors, Vasopressin

1991
Urological aspects of Wolfram's syndrome.
    European urology, 1983, Volume: 9, Issue:2

    Two new cases of Wolfram's syndrome associated with progressive urinary tract dilatation are reported. The possibility of anatomic outlet obstruction or neurogenic bladder was eliminated radiologically and urodynamically. Dilatation of the urinary tract was considered to be a consequence of high diuresis associated with diabetes insipidus. A very important improvement in bilateral urinary tract distension was achieved with bladder drainage while dDAVP therapy dramatically decreased the daily urinary output. A review of diabetes insipidus and its urological implications is presented.

    Topics: Adolescent; Blindness; Child; Deamino Arginine Vasopressin; Diabetes Complications; Diabetes Insipidus; Dilatation, Pathologic; Female; Humans; Male; Optic Atrophy; Syndrome; Urodynamics; Urologic Diseases

1983